Startups channel feed

One year af­ter leav­ing GSK, Em­manuel Hanon jumps to Medicxi-backed vac­cine start­up with an eye on RSV

3 years ago
Financing

Armed with a $48M Se­ries A, Au­ron is look­ing to ap­ply ma­chine learn­ing in can­cer treat­ment

3 years ago
Financing

'Not in to­day's mar­ket': As Am­gen, Bris­tol My­ers back an­ti­body start­up BigHat, bear mar­ket keeps IPO win­dow shut tight

3 years ago
Financing

Ex­clu­sive: Mark Pruzan­s­ki is once again reach­ing for the brass ring in biotech

3 years ago
Bioregnum

In bid to avoid im­munother­a­py tox­i­c­i­ties, Car­tog­ra­phy charts a course to­ward modal­i­ty-ag­nos­tic drugs

3 years ago
Financing

Fol­low­ing Lux­tur­na and slate of eye dis­ease ap­provals, Roche adds an­oth­er oph­thal­mol­o­gy part­ner for AAV gene ther­a­pies

3 years ago
Deals
Cell/Gene Tx

Ex­clu­sive: Af­ter Covid piv­ot, biotech nabs funds to be first in the clin­ic with a non-hor­mon­al con­tra­cep­tive for men

3 years ago
Financing

Pro­tein ther­a­peu­tics biotech us­ing 'pro­tein bar­codes' in drug de­vel­op­ment se­cures new fi­nanc­ing — led by Jeff Hu­ber

3 years ago
Financing

Pfiz­er dips its toe in­to fi­bro­sis and or­gan re­gen­er­a­tion, lead­ing raise ex­ten­sion for Bel­gium's Agomab

3 years ago
Financing

Flag­ship un­wraps new AI biotech that looks to pre­dict vari­ants be­fore they’re here

3 years ago
Financing

Big Phar­ma vet teams with for­mer Doud­na pupil to launch new epigenome start­up

3 years ago
Financing

Boehringer In­gel­heim, Evotec band with di­ag­nos­tics play­er to tack­le 'su­per­bugs' through joint ven­ture

3 years ago
Financing

Sid Mukher­jee, Lew Cant­ley be­hind new can­cer biotech with food+drug com­bo treat­ment am­bi­tions 

3 years ago
People
Financing

Ox­ford spin­out nabs al­most $100M in new cash to test PD-1 in au­toim­mune dis­eases and hunt for a CEO

3 years ago
Financing

Long­time biotech leader Pearl Huang takes the reins as CEO of No­var­tis-backed up­start

3 years ago
People

Roivant un­veils lat­est spin­out as Pfiz­er en­trusts JAK1/TYK2 to Pri­o­vant

3 years ago

Scoop: Lit­tle-known Or­biMed-backed biotech clos­es $160M round to start gene ther­a­py tri­al

3 years ago
Financing
China

Long­wood sets an­oth­er 'don't eat me' biotech in­to gear with help of for­mer Tril­li­um CEO Jan Skvar­ka

3 years ago
Financing

Car­bon Bio­sciences emerges with a new vi­ral vec­tor to shake up the cys­tic fi­bro­sis gene ther­a­py field

3 years ago
Financing
Cell/Gene Tx

Boehringer In­gel­heim to in­cu­bate biotechs with Hong Kong R&D leader

3 years ago
China

New kid on the block: Roger Perl­mut­ter's biotech signs on as an­chor ten­ant to new Bay Area cam­pus

3 years ago

Boston start­up looks to make a big man­u­fac­tur­ing push with new fund­ing round

3 years ago
Financing
Manufacturing

F-Prime-backed start­up hopes to lever­age AI and a su­per­com­put­er to emerge in pro­tein mis­fold­ing field

3 years ago
Deals
R&D

Aim­ing to har­ness the pow­er of mi­to­chon­dria, a Japan­ese start­up nets new fund­ing

3 years ago
Deals
Manufacturing
First page Previous page 38394041424344 Next page Last page
A service from the Financial Times